The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male Volunteer

NCT02004327 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Kidney Disease

Interventions

DRUG: DW1029M300mg
DRUG: DW1029M600mg
DRUG: DW1029M1200mg

Sponsor

Dong Wha Pharmaceutical Co. Ltd.